A Single Dose Study of Lu AG09222 in a Headache Model With Healthy Subjects

Status:
Active, not recruiting

Trial end date:
2021-12-03

Target enrollment:

Participant gender:

The purpose of this study is to evaluate how well Lu AG09222 can prevent blood vessel dilation in a headache model.

Phase 1

H. Lundbeck A/S